We are compiling a pool of English-speaking health care professionals for possible participation in a future research study related to primary mitochondrial disease and progressive neurological or muscular conditions. If you meet the criteria below, you may be invited to complete a short screening questionnaire to assess eligibility. This is a remote opportunity.
Eligibility:
Currently managing patients with:
Primary mitochondrial disease (priority), or
Progressive neurological or muscular conditions in adults (e.g., Parkinson’s disease, multiple sclerosis, myasthenia gravis, chronic fatigue syndrome, stroke, epilepsy, traumatic brain injury, or other rare diseases)
Use the 30-second Sit to Stand test (STS) in clinical practice and/or research to assess patients
Have administered the 30-second STS at least 20 times
Fluent in English
How to Apply:
If you meet the eligibility criteria and are interested in this opportunity, please submit your CV along with a brief statement describing your relevant experience. CV’s can also be sent to the following email: joshua.hayes@transperfect.com
Qualified candidates will be contacted with further information and invited to complete a short screening questionnaire.
DataForce delivers high-quality, multimodal training data and services to power the next generation of AI. From large language models to voice, image, and video generation, DataForce supports AI innovators in tech, life sciences, automotive, and beyond with scalable, secure solutions for development, testing, and safety. Backed by cutting-edge technology and over one million data contributors, DataForce helps ensure AI systems are accurate, adaptable, and ready for real-world deployment.
DataForce is part of TransPerfect, the world’s largest provider of language and AI solutions for global business, with offices in more than 140 cities worldwide. Learn more at www.dataforce.ai.
Contact: dataforce@transperfect.com
